We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Microlife Presents the Only Blood Pressure Monitor with Integrated AFIB Detection at MEDICA 2021

By HospiMedica International staff writers
Posted on 17 Nov 2021
Print article
Image: Microlife AG at MEDICA 2021 (Photo courtesy of Microlife AG)
Image: Microlife AG at MEDICA 2021 (Photo courtesy of Microlife AG)

Microlife AG (Widnau, ‎Switzerland) presented the only professional device for office blood pressure measurement with an integrated Atrial Fibrillation (AF) detection system at MEDICA 2021.

AF is the most common sustained cardiac arrhythmia occurring in 5% of the population older than 65 years of age and in 14% among those older than 85 years. AF leads to a 5-fold higher risk of stroke and is responsible for 20% of all strokes. Many people have no symptoms from AF and therefore remain undiagnosed, whereas early treatment can reduce the risk of stroke by 68%.

Microlife’s WatchBP Office AFIB allows AF screening during blood pressure measurement by performing Inter-Arm-Difference (IAD) measurement and simultaneously detecting AF. It features a dual-cuff design for simultaneous measurement on both arms to assess the IAD. WatchBP Office AFIB allows an optional five minute countdown time before three measurements are automatically taken with one minute interval time. It offers an auscultatory mode for use in the elderly, obese and those with arrhythmia.

The device runs on user-friendly software that allows easy data transfer and analysis. The BP measurement data can be transmitted to the PC via USB connectivity. It comes with a rechargeable battery pack that delivers up to 400~500 measurement cycles after using the power adapter. The WatchBP Office AFIB has proven its accuracy and leads to detection of more new patients with AF when used in general clinical practice.

Related Links:
Microlife AG 

Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Treadmill Test (TMT) System
GEMINI
New
Portable Patient Monitor
CMS9200PLUS

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more